tiprankstipranks
PW Medtech Group Ltd. (DE:PWE)
FRANKFURT:PWE
Germany Market
PWE
PW Medtech Group Ltd.
RESEARCH TOOLSreports

PW Medtech Group Ltd. (PWE) Ratios

0 Followers

PW Medtech Group Ltd. Ratios

DE:PWE's free cash flow for Q4 2025 was ¥0.48. For the 2025 fiscal year, DE:PWE's free cash flow was decreased by ¥ and operating cash flow was ¥0.10. See a summary of the company’s cash flow.
Ratios
TTM
Dec 25Dec 24Dec 23Dec 22
Liquidity Ratios
Current Ratio
 9.38 10.89 11.80 13.61 11.59
Quick Ratio
 8.63 10.22 11.12 12.70 10.81
Cash Ratio
 7.98 8.32 9.48 10.65 8.23
Solvency Ratio
 0.51 0.64 0.69 0.77 0.52
Operating Cash Flow Ratio
 1.28 1.11 1.79 1.41 1.60
Short-Term Operating Cash Flow Coverage
 16.84 16.05 0.00 0.00 0.00
Net Current Asset Value
¥ 1.78B¥ 2.00B¥ 1.74B¥ 1.70B¥ 1.59B
Leverage Ratios
Debt-to-Assets Ratio
 <0.01 <0.01 <0.01 <0.01 <0.01
Debt-to-Equity Ratio
 <0.01 <0.01 <0.01 <0.01 <0.01
Debt-to-Capital Ratio
 <0.01 <0.01 <0.01 <0.01 <0.01
Long-Term Debt-to-Capital Ratio
 0.00 0.00 <0.01 0.00 0.00
Financial Leverage Ratio
 1.32 1.33 1.30 1.27 1.26
Debt Service Coverage Ratio
 10.40 14.83 624.97 1.97K 315.97
Interest Coverage Ratio
 93.57 169.86 479.90 1.22K 264.75
Debt to Market Cap
 0.02 <0.01 <0.01 0.00 0.00
Interest Debt Per Share
 0.01 0.02 <0.01 <0.01 <0.01
Net Debt to EBITDA
 -8.37 -6.78 -6.16 -4.82 -7.85
Profitability Margins
Gross Profit Margin
47.88%49.48%54.55%56.42%55.67%
EBIT Margin
8.99%15.27%22.63%34.25%18.29%
EBITDA Margin
26.85%31.92%35.24%48.81%32.69%
Operating Profit Margin
8.99%14.85%23.34%27.76%22.88%
Pretax Profit Margin
14.03%20.04%29.88%34.23%29.39%
Net Profit Margin
5.36%11.46%19.61%22.69%19.75%
Continuous Operations Profit Margin
10.75%16.42%25.04%30.37%24.01%
Net Income Per EBT
38.21%57.20%65.63%66.29%67.22%
EBT Per EBIT
156.12%134.91%128.01%123.30%128.41%
Return on Assets (ROA)
0.84%1.80%2.92%2.97%2.13%
Return on Equity (ROE)
1.10%2.39%3.80%3.79%2.69%
Return on Capital Employed (ROCE)
1.47%2.44%3.60%3.75%2.55%
Return on Invested Capital (ROIC)
1.12%1.99%3.02%3.32%2.65%
Return on Tangible Assets
1.20%2.58%4.27%3.63%2.63%
Earnings Yield
3.62%5.39%10.40%13.00%12.17%
Efficiency Ratios
Receivables Turnover
 7.23 2.15 8.28 6.15 6.01
Payables Turnover
 9.63 7.07 8.36 7.56 8.55
Inventory Turnover
 2.45 2.86 2.91 2.15 1.80
Fixed Asset Turnover
 0.87 0.88 0.83 0.72 0.56
Asset Turnover
 0.16 0.16 0.15 0.13 0.11
Working Capital Turnover Ratio
 0.40 0.41 0.40 0.37 0.25
Cash Conversion Cycle
 161.45 245.37 126.09 180.52 220.77
Days of Sales Outstanding
 50.51 169.53 44.10 59.32 60.68
Days of Inventory Outstanding
 148.86 127.44 125.63 169.49 202.79
Days of Payables Outstanding
 37.91 51.60 43.65 48.29 42.70
Operating Cycle
 199.37 296.97 169.73 228.81 263.47
Cash Flow Ratios
Operating Cash Flow Per Share
 0.20 0.16 0.21 0.13 0.17
Free Cash Flow Per Share
 0.14 0.09 0.16 0.08 0.14
CapEx Per Share
 0.06 0.07 0.05 0.05 0.03
Free Cash Flow to Operating Cash Flow
 0.68 0.56 0.77 0.61 0.81
Dividend Paid and CapEx Coverage Ratio
 1.33 1.02 1.54 1.37 5.13
Capital Expenditure Coverage Ratio
 3.15 2.29 4.42 2.58 5.13
Operating Cash Flow Coverage Ratio
 13.96 10.94 26.37 187.08 63.48
Operating Cash Flow to Sales Ratio
 0.37 0.29 0.41 0.31 0.50
Free Cash Flow Yield
17.27%7.75%16.99%10.96%24.88%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 28.54 18.54 9.61 7.69 8.22
Price-to-Sales (P/S) Ratio
 1.44 2.13 1.89 1.74 1.62
Price-to-Book (P/B) Ratio
 0.31 0.44 0.37 0.29 0.22
Price-to-Free Cash Flow (P/FCF) Ratio
 5.79 12.91 5.88 9.12 4.02
Price-to-Operating Cash Flow Ratio
 4.06 7.27 4.55 5.58 3.24
Price-to-Earnings Growth (PEG) Ratio
 -0.40 -0.51 -94.03 0.17 -0.10
Price-to-Fair Value
 0.31 0.44 0.37 0.29 0.22
Enterprise Value Multiple
 -3.00 -0.12 -0.81 -1.25 -2.89
Enterprise Value
 -646.42M -30.98M -220.30M -410.57M -506.46M
EV to EBITDA
 -3.00 -0.12 -0.81 -1.25 -2.89
EV to Sales
 -0.80 -0.04 -0.29 -0.61 -0.94
EV to Free Cash Flow
 -3.23 -0.23 -0.89 -3.18 -2.34
EV to Operating Cash Flow
 -2.20 -0.13 -0.69 -1.95 -1.88
Tangible Book Value Per Share
 2.21 2.18 2.05 2.49 2.35
Shareholders’ Equity Per Share
 2.66 2.62 2.57 2.58 2.52
Tax and Other Ratios
Effective Tax Rate
 0.23 0.18 0.16 0.11 0.18
Revenue Per Share
 0.55 0.55 0.50 0.43 0.34
Net Income Per Share
 0.03 0.06 0.10 0.10 0.07
Tax Burden
 0.38 0.57 0.66 0.66 0.67
Interest Burden
 1.56 1.31 1.32 1.00 1.61
Research & Development to Revenue
 0.06 0.06 0.06 0.06 0.08
SG&A to Revenue
 0.34 0.33 0.31 0.18 0.23
Stock-Based Compensation to Revenue
 0.00 0.00 0.02 0.00 0.00
Income Quality
 3.19 2.62 1.39 0.91 2.54
Currency in CNY